Moscow wants to ramp up foreign production of its Sputnik V COVID-19 vaccine after it was deemed safe and effective according to advanced trial data provided by Russia and published in The Lancet, a British medical journal. The vaccine was initially criticized for being hastily rolled out in August before any large-scale trials had begun. But now that those trials have started and are getting positive reviews, the Kremlin hopes to bolster the vaccine’s use around the world.

This post was originally published on Radio Free.